Scinai Immunotherapeutics (SCNI) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

SCNI is expected to report earnings to fall 3,548.28% to -10 cents per share on May 02

Scinai Immunotherapeutics SCNI Stock Earnings Reports

Q4'22

Est.

$-0.10

Q3'22

Beat

by $0.10

Q2'22

Est.

$-0.01

Q1'22

Est.

$0.00

The last earnings report on November 30 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 144.75K shares outstanding, the current market capitalization sits at 3.05M.

View a ticker or compare two or three

Compare

SCNI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SCNI
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of the innovative flu vaccine

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

Hadassah Ein Kerem Campus

Phone

+972 89302529

Employees

Web

https://www.biondvax.com